Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): The "real-life setting" proves the concept

European Journal of Medical Research

Volumn 16, Issue 5, 2011, Pages 237-242

  Obermeier, M ^a   Ingiliz, P ^a   Weitner, L ^b   Cordes, C ^c   Moll, A ^d   Hintsche, B ^e   Schlote, F ^f   Koeppe, S ^g   Christensen, S ^h   Mayr, C ⁱ   Baumgarten, Axel ^a  

^a Medical Center for Infectious Diseases (MIB)   (Germany)

^b Infektionsmedizinisches Centrum Hamburg   (Germany)

^c PraxisCityOst   (Germany)

^d Praxiszentrum Kaiserdamm   (Germany)

^e Private Practice Hintsche / Klausen   (Germany)

^f Praxis Turmstrasse   (Germany)

^g Praxis Köppe Kreckel   (Germany)

^h Center for Interdisciplinary Medicine   (Germany)

ⁱ Practice Aerzteforum Seestraße   (Germany)

Author keywords

Acute hepatitis C; HIV; Interferon; Spontaneous clearance; SVR

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TREATMENT DURATION; VIRUS LOAD; ACUTE HEPATITIS C; GENOTYPE; GERMANY; HOMOSEXUAL MALE; MEDICAL DECISION MAKING; RISK FACTOR; THROMBOCYTE COUNT; VIRAL CLEARANCE;

EID: 79957616506     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-5-237     Document Type: Article

References (36)

1. Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, Gazzard BG, Nelson MR. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr. 2005 Sep 1; 40(1): 41-6. (Pubitemid 41233203)
2. Vogel M, Bieniek B, Jessen H, Schewe CK, Hoffmann C, Baumgarten A, Kroidl A, Bogner JR, Spengler U, Rockstroh JK. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat. 2005 Mar; 12(2): 207-11. (Pubitemid 40342180)
3. Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS. 2006 May 12; 20(8): 1157-61
4. Götz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. AIDS. 2005 Jun 10; 19(9): 969-74. (Pubitemid 40834941)
5. van de Laar TJ, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JT, de Vries HJ, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007 Jul 15; 196(2): 230-8. (Pubitemid 47047462)
6. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Jan 1; 41(1): 31-6. (Pubitemid 41786016)
7. Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, McCaughan G, Sasadeusz J, White P, Rawlinson W, Lloyd A, Kaldor J, Dore GJ; Australian Trial in Acute Hepatitis C Study Group. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis. 2009 Mar 1; 48(5): 650-8.
8. Marcus U, Voss L, Kollan C, Hamouda O. HIV incidence increasing in MSM in Germany: factors influencing infection dynamics. Eur Surveill. 2006 Sep; 11(9): 157-60.
9. van der Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White P, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M. Evidence of a Large, International Network of HCV Transmission in HIVPositive Men Who Have Sex With Men. Gastroenterology. 2009 May; 136(5): 1609-17
10. Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003 Oct 1; 34(2): 165-73. (Pubitemid 37248913)
11. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Feb 1; 32(3): 492-97. (Pubitemid 32173638)
12. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999 Oct; 30(4): 1054-8.
13. Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, Bhagani S, Emery VC, Dusheiko GM, Klenerman P. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008 Jun 1; 197(11): 1558-66. (Pubitemid 351706486)
14. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infec- tion: a meta-analysis. Clin Infect Dis. 2001 Aug 15; 33(4): 562-69. (Pubitemid 32709592)
15. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000 Nov 25; 356(9244): 1800-05.
16. Vogel M, Rockstroh JK. Treatment of acute hepatitis C in HIV infection. J Antimicrob Chemother. 2010 Jan; 65(1): 4-9.
17. Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, Guiguet M, Valantin MA, Katlama C, Rockstroh JK, Nelson M. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort. Antivir Ther. 2010; 15(2): 267-79.
18. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41(RR-17): 1-19.
19. Rauch A, Rickenbach M, Weber R, Hirschel B, Tarr PE, Bucher HC, Vernazza P, Bernasconi E, Zinkernagel AS, Evison J, Furrer H. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HlV Cohort Study. Clin Infect Dis 2005 Aug 1; 41(3): 395-402. (Pubitemid 41022120)
20. Ghosn J, Deveau C, Goujard C, Garrigue I, Saichi N, Galimand J, Nagy Z, Rouzioux C, Meyer L, Chaix ML. Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection. Sex Transm Infect. 2006 Dec; 82(6): 458-60. (Pubitemid 46025186)
21. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4 T cells in multiple tissues during acute SIV infection. Nature. 2005 Apr 28; 434(7037): 1093-97. (Pubitemid 40663481)
22. van de Laar TJ, Paxton WA, Zorgdrager F, Cornelissen M, de Vries HJ. Sexual transmission of hepatitis C virus in human immunodeficiency virus-negative men who have sex with men: a series of case reports. Sex Transm Dis 2011 Feb; 38(2): 102-4.
23. Matthews-Greer JM, Caldito GC, Adley SD, Willis R, Mire AC, Jamison RM, McRae KL, King JW, Chang WL. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol. 2001 Jul; 8(4): 690-94. (Pubitemid 32613692)
24. Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J, Gilson R, Fisher M, Bhagani S, Johnson M, Barton S. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect. 2008 Apr; 84(2): 111-5.
25. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009 Jul 31; 23(12): F1-7.
26. Ghosn J, Deveau C, Goujard C, Garrigue I, Saichi N, Galimand J, Nagy Z, Rouzioux C, Meyer L, Chaix ML. Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection. Sex Transm Infect. 2006 Dec; 82(6): 458-60. (Pubitemid 46025186)
27. Baumgarten A, Hofmann C, Obermeier M. Hepatitis C coinfection in HIV-infected patients - evidence for considerable undertreatment. European AIDS Conference 2009; Cologne, Germany: Poster PE13.2/9
28. Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006 Aug 14-28; 166(15): 1632-41.
29. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 2003 Jul; 125(1): 80-8. (Pubitemid 36799109)
30. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP; German Acute Hepatitis C Therapy Group. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001 Nov 15; 345(20): 1452-57.
31. Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006 Feb; 43(2): 250-56.
32. Vogel M, Nattermann J, Baumgarten A, Klausen G, Bieniek B, Schewe K.Jessen H, Boesecke C, Rausch M, Lutz T, Fenske S, Schranz D, Kümmerle T, Schuler C, Theisen A, Mayr C, Seidel T, Rockstroh JK. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther 2006; 11(8): 1097-101.
33. Matthews GV, Grebely J, Hellard M, Yeung B, Marks P, Rawlinson W, Kaldor J, Dore G, ATAHC Study Group et al. Differences in early virological decline in individuals treated in the Australian Trial in Acute HCV suggest a potential benefit for the use of ribavirin. EASL conference 2010, Vienna, Austria, oral presentation.
34. Azwa A, Vogel M, Bhagani S, et al. The natural history of acute hepatitis C (AHC) in HIV co-infected individuals - a European collaborative study. In: Abstracts of the Eleventh European AIDS Conference, Madrid, Spain, 2007. Abstract PS8/5.
35. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000 Jul 26; 284(4): 450-6.
36. Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, Bhagani S, Emery VC, Dusheiko GM, Klenerman P. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008 Jun 1; 197(11): 1558-66. (Pubitemid 351706486)